nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—Breast enlargement—Spironolactone—dilated cardiomyopathy	0.0369	0.0388	CcSEcCtD
Cyclobenzaprine—Indecainide—SCN5A—dilated cardiomyopathy	0.0299	0.627	CrCbGaD
Cyclobenzaprine—Cerebration impaired—Furosemide—dilated cardiomyopathy	0.0222	0.0233	CcSEcCtD
Cyclobenzaprine—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.0214	0.0225	CcSEcCtD
Cyclobenzaprine—Cholestasis—Furosemide—dilated cardiomyopathy	0.0172	0.018	CcSEcCtD
Cyclobenzaprine—Inappropriate antidiuretic hormone secretion—Lisinopril—dilated cardiomyopathy	0.0168	0.0177	CcSEcCtD
Cyclobenzaprine—Ataxia—Spironolactone—dilated cardiomyopathy	0.0163	0.0172	CcSEcCtD
Cyclobenzaprine—Gastritis—Spironolactone—dilated cardiomyopathy	0.0154	0.0161	CcSEcCtD
Cyclobenzaprine—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.015	0.0158	CcSEcCtD
Cyclobenzaprine—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.0149	0.0156	CcSEcCtD
Cyclobenzaprine—Bone marrow depression—Lisinopril—dilated cardiomyopathy	0.0145	0.0152	CcSEcCtD
Cyclobenzaprine—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.0138	0.0145	CcSEcCtD
Cyclobenzaprine—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0134	0.0141	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.0125	0.0131	CcSEcCtD
Cyclobenzaprine—Mental disability—Furosemide—dilated cardiomyopathy	0.0113	0.0119	CcSEcCtD
Cyclobenzaprine—Alopecia—Spironolactone—dilated cardiomyopathy	0.0106	0.0112	CcSEcCtD
Cyclobenzaprine—Vascular purpura—Furosemide—dilated cardiomyopathy	0.0106	0.0111	CcSEcCtD
Cyclobenzaprine—Thirst—Furosemide—dilated cardiomyopathy	0.00993	0.0104	CcSEcCtD
Cyclobenzaprine—Purpura—Furosemide—dilated cardiomyopathy	0.00981	0.0103	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00971	0.0102	CcSEcCtD
Cyclobenzaprine—Malaise—Spironolactone—dilated cardiomyopathy	0.00944	0.00991	CcSEcCtD
Cyclobenzaprine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00937	0.00984	CcSEcCtD
Cyclobenzaprine—Irritability—Furosemide—dilated cardiomyopathy	0.00902	0.00948	CcSEcCtD
Cyclobenzaprine—Urinary retention—Furosemide—dilated cardiomyopathy	0.00899	0.00944	CcSEcCtD
Cyclobenzaprine—Discomfort—Spironolactone—dilated cardiomyopathy	0.0088	0.00924	CcSEcCtD
Cyclobenzaprine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00861	0.00904	CcSEcCtD
Cyclobenzaprine—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00857	0.00899	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00854	0.00897	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00836	0.00878	CcSEcCtD
Cyclobenzaprine—Carbamazepine—SCN5A—dilated cardiomyopathy	0.00823	0.173	CrCbGaD
Cyclobenzaprine—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00812	0.00852	CcSEcCtD
Cyclobenzaprine—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00809	0.0085	CcSEcCtD
Cyclobenzaprine—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00765	0.00803	CcSEcCtD
Cyclobenzaprine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00759	0.00797	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00755	0.00793	CcSEcCtD
Cyclobenzaprine—Drowsiness—Furosemide—dilated cardiomyopathy	0.00729	0.00765	CcSEcCtD
Cyclobenzaprine—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00724	0.0076	CcSEcCtD
Cyclobenzaprine—Diplopia—Lisinopril—dilated cardiomyopathy	0.00709	0.00745	CcSEcCtD
Cyclobenzaprine—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00709	0.00745	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00704	0.00739	CcSEcCtD
Cyclobenzaprine—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00704	0.00739	CcSEcCtD
Cyclobenzaprine—Sweating—Furosemide—dilated cardiomyopathy	0.00698	0.00733	CcSEcCtD
Cyclobenzaprine—Face oedema—Lisinopril—dilated cardiomyopathy	0.00685	0.00719	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.0068	0.00714	CcSEcCtD
Cyclobenzaprine—Urticaria—Spironolactone—dilated cardiomyopathy	0.00679	0.00712	CcSEcCtD
Cyclobenzaprine—Irritability—Lisinopril—dilated cardiomyopathy	0.00677	0.00711	CcSEcCtD
Cyclobenzaprine—Ataxia—Lisinopril—dilated cardiomyopathy	0.00667	0.007	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00629	0.00661	CcSEcCtD
Cyclobenzaprine—Gastritis—Lisinopril—dilated cardiomyopathy	0.00628	0.00659	CcSEcCtD
Cyclobenzaprine—Tinnitus—Furosemide—dilated cardiomyopathy	0.0061	0.0064	CcSEcCtD
Cyclobenzaprine—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00607	0.00637	CcSEcCtD
Cyclobenzaprine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00604	0.00635	CcSEcCtD
Cyclobenzaprine—Orphenadrine—SCN5A—dilated cardiomyopathy	0.00593	0.124	CrCbGaD
Cyclobenzaprine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00584	0.00614	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00584	0.00614	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00582	0.00611	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.0057	0.00598	CcSEcCtD
Cyclobenzaprine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00565	0.00593	CcSEcCtD
Cyclobenzaprine—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00565	0.00593	CcSEcCtD
Cyclobenzaprine—Flatulence—Furosemide—dilated cardiomyopathy	0.00561	0.00589	CcSEcCtD
Cyclobenzaprine—Weight increased—Lisinopril—dilated cardiomyopathy	0.00558	0.00586	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00558	0.00585	CcSEcCtD
Cyclobenzaprine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00543	0.0057	CcSEcCtD
Cyclobenzaprine—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00539	0.00566	CcSEcCtD
Cyclobenzaprine—Rash—Spironolactone—dilated cardiomyopathy	0.00539	0.00565	CcSEcCtD
Cyclobenzaprine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00538	0.00565	CcSEcCtD
Cyclobenzaprine—Vision blurred—Furosemide—dilated cardiomyopathy	0.00537	0.00563	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00536	0.00563	CcSEcCtD
Cyclobenzaprine—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00536	0.00563	CcSEcCtD
Cyclobenzaprine—Headache—Spironolactone—dilated cardiomyopathy	0.00535	0.00562	CcSEcCtD
Cyclobenzaprine—Jaundice—Lisinopril—dilated cardiomyopathy	0.00533	0.0056	CcSEcCtD
Cyclobenzaprine—Sweating—Lisinopril—dilated cardiomyopathy	0.00524	0.0055	CcSEcCtD
Cyclobenzaprine—Agitation—Furosemide—dilated cardiomyopathy	0.00523	0.00549	CcSEcCtD
Cyclobenzaprine—Vertigo—Furosemide—dilated cardiomyopathy	0.00512	0.00537	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.0051	0.00536	CcSEcCtD
Cyclobenzaprine—Leukopenia—Furosemide—dilated cardiomyopathy	0.0051	0.00535	CcSEcCtD
Cyclobenzaprine—Nausea—Spironolactone—dilated cardiomyopathy	0.00507	0.00533	CcSEcCtD
Cyclobenzaprine—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00491	0.00515	CcSEcCtD
Cyclobenzaprine—Hallucination—Lisinopril—dilated cardiomyopathy	0.00488	0.00513	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00487	0.00511	CcSEcCtD
Cyclobenzaprine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00474	0.00498	CcSEcCtD
Cyclobenzaprine—Confusional state—Furosemide—dilated cardiomyopathy	0.00469	0.00492	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00465	0.00488	CcSEcCtD
Cyclobenzaprine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00458	0.0048	CcSEcCtD
Cyclobenzaprine—Shock—Furosemide—dilated cardiomyopathy	0.00457	0.0048	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00455	0.00478	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00449	0.00472	CcSEcCtD
Cyclobenzaprine—Anorexia—Furosemide—dilated cardiomyopathy	0.00443	0.00465	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00438	0.0046	CcSEcCtD
Cyclobenzaprine—Hypotension—Furosemide—dilated cardiomyopathy	0.00434	0.00456	CcSEcCtD
Cyclobenzaprine—Alopecia—Lisinopril—dilated cardiomyopathy	0.00434	0.00455	CcSEcCtD
Cyclobenzaprine—Flatulence—Lisinopril—dilated cardiomyopathy	0.00421	0.00442	CcSEcCtD
Cyclobenzaprine—Tension—Lisinopril—dilated cardiomyopathy	0.00419	0.0044	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00418	0.00439	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00417	0.00438	CcSEcCtD
Cyclobenzaprine—Nervousness—Lisinopril—dilated cardiomyopathy	0.00415	0.00436	CcSEcCtD
Cyclobenzaprine—Somnolence—Furosemide—dilated cardiomyopathy	0.00413	0.00434	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00404	0.00424	CcSEcCtD
Cyclobenzaprine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00403	0.00423	CcSEcCtD
Cyclobenzaprine—Fatigue—Furosemide—dilated cardiomyopathy	0.00401	0.00421	CcSEcCtD
Cyclobenzaprine—Tremor—Lisinopril—dilated cardiomyopathy	0.004	0.0042	CcSEcCtD
Cyclobenzaprine—Constipation—Furosemide—dilated cardiomyopathy	0.00397	0.00417	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00396	0.00416	CcSEcCtD
Cyclobenzaprine—Angioedema—Lisinopril—dilated cardiomyopathy	0.0039	0.0041	CcSEcCtD
Cyclobenzaprine—Malaise—Lisinopril—dilated cardiomyopathy	0.00385	0.00405	CcSEcCtD
Cyclobenzaprine—Vertigo—Lisinopril—dilated cardiomyopathy	0.00384	0.00403	CcSEcCtD
Cyclobenzaprine—Syncope—Lisinopril—dilated cardiomyopathy	0.00383	0.00402	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00383	0.00402	CcSEcCtD
Cyclobenzaprine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00382	0.00402	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.0038	0.00399	CcSEcCtD
Cyclobenzaprine—Palpitations—Lisinopril—dilated cardiomyopathy	0.00378	0.00396	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00375	0.00394	CcSEcCtD
Cyclobenzaprine—Urticaria—Furosemide—dilated cardiomyopathy	0.00369	0.00388	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00367	0.00386	CcSEcCtD
Cyclobenzaprine—Chest pain—Lisinopril—dilated cardiomyopathy	0.00364	0.00382	CcSEcCtD
Cyclobenzaprine—Myalgia—Lisinopril—dilated cardiomyopathy	0.00364	0.00382	CcSEcCtD
Cyclobenzaprine—Anxiety—Lisinopril—dilated cardiomyopathy	0.00362	0.00381	CcSEcCtD
Cyclobenzaprine—Diphenhydramine—SLC22A5—dilated cardiomyopathy	0.00361	0.0757	CrCbGaD
Cyclobenzaprine—Discomfort—Lisinopril—dilated cardiomyopathy	0.00359	0.00377	CcSEcCtD
Cyclobenzaprine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00356	0.00374	CcSEcCtD
Cyclobenzaprine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00352	0.00369	CcSEcCtD
Cyclobenzaprine—Oedema—Lisinopril—dilated cardiomyopathy	0.00349	0.00366	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00349	0.00366	CcSEcCtD
Cyclobenzaprine—Shock—Lisinopril—dilated cardiomyopathy	0.00343	0.0036	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00342	0.0036	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00341	0.00358	CcSEcCtD
Cyclobenzaprine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.0034	0.00357	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00337	0.00354	CcSEcCtD
Cyclobenzaprine—Asthenia—Furosemide—dilated cardiomyopathy	0.00333	0.0035	CcSEcCtD
Cyclobenzaprine—Anorexia—Lisinopril—dilated cardiomyopathy	0.00332	0.00349	CcSEcCtD
Cyclobenzaprine—Pruritus—Furosemide—dilated cardiomyopathy	0.00329	0.00345	CcSEcCtD
Cyclobenzaprine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00326	0.00342	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00318	0.00334	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00318	0.00334	CcSEcCtD
Cyclobenzaprine—Insomnia—Lisinopril—dilated cardiomyopathy	0.00315	0.00331	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00313	0.00329	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00311	0.00326	CcSEcCtD
Cyclobenzaprine—Somnolence—Lisinopril—dilated cardiomyopathy	0.0031	0.00325	CcSEcCtD
Cyclobenzaprine—Dizziness—Furosemide—dilated cardiomyopathy	0.00307	0.00323	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00307	0.00322	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00303	0.00318	CcSEcCtD
Cyclobenzaprine—Fatigue—Lisinopril—dilated cardiomyopathy	0.00301	0.00316	CcSEcCtD
Cyclobenzaprine—Constipation—Lisinopril—dilated cardiomyopathy	0.00298	0.00313	CcSEcCtD
Cyclobenzaprine—Vomiting—Furosemide—dilated cardiomyopathy	0.00295	0.0031	CcSEcCtD
Cyclobenzaprine—Rash—Furosemide—dilated cardiomyopathy	0.00293	0.00308	CcSEcCtD
Cyclobenzaprine—Dermatitis—Furosemide—dilated cardiomyopathy	0.00293	0.00307	CcSEcCtD
Cyclobenzaprine—Headache—Furosemide—dilated cardiomyopathy	0.00291	0.00306	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00287	0.00302	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00285	0.00299	CcSEcCtD
Cyclobenzaprine—Urticaria—Lisinopril—dilated cardiomyopathy	0.00277	0.00291	CcSEcCtD
Cyclobenzaprine—Nausea—Furosemide—dilated cardiomyopathy	0.00276	0.0029	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00276	0.00289	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00257	0.0027	CcSEcCtD
Cyclobenzaprine—Asthenia—Lisinopril—dilated cardiomyopathy	0.0025	0.00263	CcSEcCtD
Cyclobenzaprine—Pruritus—Lisinopril—dilated cardiomyopathy	0.00247	0.00259	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00239	0.0025	CcSEcCtD
Cyclobenzaprine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00231	0.00242	CcSEcCtD
Cyclobenzaprine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00222	0.00233	CcSEcCtD
Cyclobenzaprine—Rash—Lisinopril—dilated cardiomyopathy	0.0022	0.00231	CcSEcCtD
Cyclobenzaprine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.0022	0.00231	CcSEcCtD
Cyclobenzaprine—Headache—Lisinopril—dilated cardiomyopathy	0.00218	0.00229	CcSEcCtD
Cyclobenzaprine—Nausea—Lisinopril—dilated cardiomyopathy	0.00207	0.00217	CcSEcCtD
